Reported 9 months ago
This article discusses two beaten-down dividend stocks, Pfizer and Realty Income, which currently offer yields above 5%. Despite their recent declines, both stocks have the potential for long-term growth and steady dividend payouts. Pfizer's falling stock price is attributed to declining sales of its COVID-19 products, but the company remains poised for significant profit growth with recent acquisitions. Meanwhile, Realty Income faces challenges due to underperforming tenants, but its well-diversified portfolio and consistent dividend increases make it an attractive investment option for income-seeking investors.
Source: YAHOO